The Active Tamoxifen Metabolite Endoxifen (4OHNDtam) Strongly Down-Regulates Cytokeratin 6 (CK6) in McF-7 Breast Cancer Cells

PLoS ONE- United States

doi 10.1371/journal.pone.0122339

Full Text

Abstract

Available in

Date

Authors

Publisher

Public Library of Science (PLoS)

Related search

Simvastatin Evokes an Unpredicted Antagonism for Tamoxifen in McF-7 Breast Cancer Cells

Cancer Management and Research
Oncology
2019English

Epanorin, a Lichen Secondary Metabolite, Inhibits Proliferation of McF-7 Breast Cancer Cells

Biological Research
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgricultural
2019English

Modulation of Tamoxifen Cytotoxicity by Caffeic Acid Phenethyl Ester in McF-7 Breast Cancer Cells

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2016English

Heregulin Β1 Drives Gefitinib-Resistant Growth and Invasion in Tamoxifen-Resistant McF-7 Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2007English

Piperine in the Prevention of the Decreased Tamoxifen Sensitivity in McF-7 Breast Cancer Cell Line

International Journal of Applied Pharmaceutics
Pharmaceutical Science
2018English

Induction of UDP-Glucuronosyltransferase 2B15 Gene Expression by the Major Active Metabolites of Tamoxifen, 4-Hydroxytamoxifen and Endoxifen, in Breast Cancer Cells

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2015English

The Effect of Melatonin on McF-7 Breast Cancer Cells in Vitro

Endocrine Abstracts
2015English

Icariin Induces Apoptosis by Suppressing Autophagy in Tamoxifen-Resistant Breast Cancer Cell Line McF-7/Tam

Breast Cancer
Nuclear MedicineRadiologyPharmacologyOncologyImagingMedicine
2019English

Quantitative Organelle Proteomics of Protein Distribution in Breast Cancer McF-7 Cells

2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy